(b)(4).Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that patient was experiencing painful stim, continuous stim, and lead protrusion.The np believes that these symptoms are due to the vns.All modes were disabled on the device outside of autostimulation.The symptoms persisted.All modes were disabled and the symptoms went away.Diagnostics are okay.Patient received x-rays, no anomalies were seen.The patient was referred to the neuro surgeon.Data was sent to the manufacturer for review in which no anomalies were detected.It is likely that the programmed heart rate detection threshold was too sensitive for the patient.No known relevant surgical intervention has occurred to date.No other relevant information has been received to date.
|